Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Travera Inc
University of Nebraska
Takeda
Perspective Therapeutics
Novartis
VM Oncology, LLC
NeoTX Therapeutics Ltd.
CRISPR Therapeutics
Stella Pharma Corporation
Actym Therapeutics, Inc.
NuCana plc
Telix Pharmaceuticals (Innovations) Pty Limited
Medicenna Therapeutics, Inc.
Ascentage Pharma Group Inc.
Cancer Research UK
Alliance for Clinical Trials in Oncology
Aminex Therapeutics, Inc.
Taproot Health
Symphogen A/S
Travera Inc
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Centre Hospitalier Universitaire Vaudois
Massachusetts General Hospital
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
Quadriga Biosciences, Inc.
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Shionogi Inc.
Incyte Corporation
Incyte Corporation
University of Maryland, Baltimore
Incyte Corporation
Abramson Cancer Center at Penn Medicine
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Shenzhen BinDeBio Ltd.
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Swiss Cancer Institute
National Institutes of Health Clinical Center (CC)
Stanford University
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
INSYS Therapeutics Inc